{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:56:58Z","timestamp":1780473418920,"version":"3.54.1"},"reference-count":151,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":1349,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2022,3,27]],"date-time":"2022-03-27T00:00:00Z","timestamp":1648339200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Wild-type transthyretin amyloid cardiomyopathy (ATTRwt CM) is a more common disease than previously thought. Awareness of ATTRwt CM and its diagnosis has been challenged by its unspecific and widely distributed clinical manifestations and traditionally invasive diagnostic tools. Recent advances in echocardiography and cardiac magnetic resonance (CMR), non-invasive diagnosis by bone scintigraphy, and the development of disease-modifying treatments have resulted in an increased interest, reflected in multiple publications especially during the last decade. To get an overview of the scientific knowledge and gaps related to patient entry, suspicion, diagnosis, and systematic screening of ATTRwt CM, we developed a framework to systematically map the available evidence of (i) when to suspect ATTRwt CM in a patient, (ii) how to diagnose the disease, and (iii) which at-risk populations to screen for ATTRwt CM. Articles published between 2010 and August 2021 containing part of or a full diagnostic pathway for ATTRwt CM were included. From these articles, data for patient entry, suspicion, diagnosis, and screening were extracted, as were key study design and results from the original studies referred to. A total of 50 articles met the inclusion criteria. Of these, five were position statements from academic societies, while one was a clinical guideline. Three articles discussed the importance of primary care providers in terms of patient entry, while the remaining articles had the cardiovascular setting as point of departure. The most frequently mentioned suspicion criteria were ventricular wall thickening (44\/50), carpal tunnel syndrome (42\/50), and late gadolinium enhancement on CMR (43\/50). Diagnostic pathways varied slightly, but most included bone scintigraphy, exclusion of light-chain amyloidosis, and the possibility of doing a biopsy. Systematic screening was mentioned in 16 articles, 10 of which suggested specific at-risk populations for screening. The European Society of Cardiology recommends to screen patients with a wall thickness \u226512 mm and heart failure, aortic stenosis, or red flag symptoms, especially if they are &amp;gt;65 years. The underlying evidence was generally good for diagnosis, while significant gaps were identified for the relevance and mutual ranking of the different suspicion criteria and for systematic screening. Conclusively, patient entry was neglected in the reviewed literature. While multiple red flags were described, high-quality prospective studies designed to evaluate their suitability as suspicion criteria were lacking. An upcoming task lies in defining and evaluating at-risk populations for screening. All are steps needed to promote early detection and diagnosis of ATTRwt CM, a prerequisite for timely treatment.<\/jats:p>","DOI":"10.1002\/ehf2.13884","type":"journal-article","created":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T01:39:41Z","timestamp":1648431581000},"page":"1524-1541","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Suspicion, Screening, and Diagnosis of Wild-Type Transthyretin Amyloid Cardiomyopathy: A Systematic Literature Review"],"prefix":"10.1093","volume":"9","author":[{"given":"Katrine","family":"Bay","sequence":"first","affiliation":[{"name":"Bay Writing , Copenhagen ,","place":["Denmark"]},{"name":"Pfizer Denmark , Ballerup ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finn","family":"Gustafsson","sequence":"additional","affiliation":[{"name":"The Heart Center, Copenhagen University Hospital, Rigshospitalet , Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Maiborg","sequence":"additional","affiliation":[{"name":"Odense Amyloidosis Center & Department of Cardiology, Odense University Hospital , Odense ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Bagger-Bahnsen","sequence":"additional","affiliation":[{"name":"Pfizer Denmark , Ballerup ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Mette","family":"Strand","sequence":"additional","affiliation":[{"name":"Pfizer Denmark , Ballerup ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trine","family":"Pilgaard","sequence":"additional","affiliation":[{"name":"Pfizer Denmark , Ballerup ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steen Hvitfeldt","family":"Poulsen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Aarhus University Hospital , Aarhus ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,3,27]]},"reference":[{"key":"2026012114234249100_ehf213884-bib-0001","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1093\/eurheartj\/ehv338","article-title":"Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction","volume":"36","author":"Gonz\u00e1lez-L\u00f3pez","year":"2015","journal-title":"Eur Heart J"},{"key":"2026012114234249100_ehf213884-bib-0002","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00392-020-01799-3","article-title":"Diagnosis and treatment of cardiac amyloidosis: position statement of the German Cardiac Society (DGK)","volume":"110","author":"Yilmaz","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"2026012114234249100_ehf213884-bib-0003","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/eurheartj\/ehx043","article-title":"Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths","volume":"38","author":"Gonz\u00e1lez-L\u00f3pez","year":"2017","journal-title":"Eur Heart J"},{"key":"2026012114234249100_ehf213884-bib-0004","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jchf.2019.04.010","article-title":"Screening for transthyretin amyloid cardiomyopathy in everyday practice","volume":"7","author":"Witteles","year":"2019","journal-title":"JACC Heart Fail"},{"key":"2026012114234249100_ehf213884-bib-0005","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12875-020-01252-4","article-title":"Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner","volume":"21","author":"Gertz","year":"2020","journal-title":"BMC Fam Pract"},{"key":"2026012114234249100_ehf213884-bib-0006","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"key":"2026012114234249100_ehf213884-bib-0007","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N Engl J Med"},{"key":"2026012114234249100_ehf213884-bib-0008","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1716793","article-title":"Inotersen treatment for patients with hereditary transthyretin amyloidosis","volume":"379","author":"Benson","year":"2018","journal-title":"N Engl J Med"},{"key":"2026012114234249100_ehf213884-bib-0009","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"8","author":"Moher","year":"2010","journal-title":"Int J Surg"},{"key":"2026012114234249100_ehf213884-bib-0010","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","article-title":"Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review","volume":"73","author":"Ruberg","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026012114234249100_ehf213884-bib-0011","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1016\/j.jacc.2015.09.075","article-title":"Diagnosis, prognosis, and therapy of transthyretin amyloidosis","volume":"66","author":"Gertz","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026012114234249100_ehf213884-bib-0012","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s10741-016-9580-5","article-title":"Recent advances in the noninvasive strategies of cardiac amyloidosis","volume":"21","author":"Zhao","year":"2016","journal-title":"Heart Fail Rev"},{"key":"2026012114234249100_ehf213884-bib-0013","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.recesp.2017.05.018","article-title":"Diagnosis and treatment of transthyretin cardiac amyloidosis. Progress and hope","volume":"70","author":"Gonz\u00e1lez-L\u00f3pez","year":"2017","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"2026012114234249100_ehf213884-bib-0014","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/HCO.0000000000000547","article-title":"Amyloidosis cardiomyopathy: update in the diagnosis and treatment of the most common types","volume":"33","author":"Nativi-Nicolau","year":"2018","journal-title":"Curr Opin Cardiol"},{"key":"2026012114234249100_ehf213884-bib-0015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11886-019-1097-9","article-title":"Molecular imaging of cardiac amyloidosis","volume":"21","author":"Pelletier-Galarneau","year":"2019","journal-title":"Curr Cardiol Rep"},{"key":"2026012114234249100_ehf213884-bib-0016","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s11886-019-1180-2","article-title":"Cardiac amyloidosis: updates in imaging","volume":"21","author":"Chacko","year":"2019","journal-title":"Curr Cardiol Rep"},{"key":"2026012114234249100_ehf213884-bib-0017","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1080\/14779072.2019.1662723","article-title":"Amyloid transthyretin cardiac amyloidosis: diagnosis and management","volume":"17","author":"Di Giovanni","year":"2019","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"2026012114234249100_ehf213884-bib-0018","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s11897-019-00446-x","article-title":"Amyloidosis in heart failure","volume":"16","author":"Ihne","year":"2019","journal-title":"Curr Heart Fail Rep"},{"key":"2026012114234249100_ehf213884-bib-0019","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.tcm.2019.12.003","article-title":"Transthyretin cardiac amyloidosis: a treatable form of heart failure with a preserved ejection fraction","volume":"31","author":"Griffin","year":"2021","journal-title":"Trends Cardiovasc Med"},{"key":"2026012114234249100_ehf213884-bib-0020","first-page":"1","article-title":"Cardiac amyloidosis: recent advances in the diagnosis and therapy","volume":"47","author":"\u00c7avu\u015fo\u011flu","year":"2019","journal-title":"Turk Kardiyol Dern Ars"},{"key":"2026012114234249100_ehf213884-bib-0021","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s40119-020-00169-4","article-title":"Diagnosis of transthyretin amyloid cardiomyopathy","volume":"9","author":"Hafeez","year":"2020","journal-title":"Cardiol Ther"},{"key":"2026012114234249100_ehf213884-bib-0022","article-title":"Diagnosing cardiac amyloidosis in every-day practice: a practical guide for the cardiologist","volume":"28","author":"Papathanasiou","year":"2020","journal-title":"Int J Cardiol Heart Vasc"},{"key":"2026012114234249100_ehf213884-bib-0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100720","article-title":"The diagnostic challenges of cardiac amyloidosis: a practical approach to the two main types","volume":"45","author":"Varga","year":"2021","journal-title":"Blood Rev"},{"key":"2026012114234249100_ehf213884-bib-0024","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s11886-019-1230-9","article-title":"Amyloid and the heart","volume":"21","author":"Wolfson","year":"2019","journal-title":"Curr Cardiol Rep"},{"key":"2026012114234249100_ehf213884-bib-0025","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1016\/j.jacc.2020.04.022","article-title":"Cardiac scintigraphy with technetium-99m-labeled bone-seeking tracers for suspected amyloidosis: JACC review topic of the week","volume":"75","author":"Hanna","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026012114234249100_ehf213884-bib-0026","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3909\/ricm0887","article-title":"A focused review on the pathophysiology, diagnosis, and management of cardiac amyloidosis","volume":"18","author":"Lo Presti","year":"2017","journal-title":"Rev Cardiovasc Med"},{"key":"2026012114234249100_ehf213884-bib-0027","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/ehjci\/jeaa063","article-title":"Multimodality imaging in cardiac amyloidosis: a primer for cardiologists","volume":"21","author":"Jurcu\u0163","year":"2020","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026012114234249100_ehf213884-bib-0028","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cpcardiol.2012.11.002","article-title":"Current trends in diagnosis and management of cardiac amyloidosis","volume":"38","author":"Esplin","year":"2013","journal-title":"Curr Probl Cardiol"},{"key":"2026012114234249100_ehf213884-bib-0029","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/joim.12383","article-title":"Cardiac amyloidosis: where are we today?","volume":"278","author":"Patel","year":"2015","journal-title":"J Intern Med"},{"key":"2026012114234249100_ehf213884-bib-0030","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.amjmed.2011.04.013","article-title":"Cardiac amyloidosis: a practical approach to diagnosis and management","volume":"124","author":"Kapoor","year":"2011","journal-title":"Am J Med"},{"key":"2026012114234249100_ehf213884-bib-0031","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1016\/S0140-6736(15)01274-X","article-title":"Systemic amyloidosis","volume":"387","author":"Wechalekar","year":"2016","journal-title":"Lancet"},{"key":"2026012114234249100_ehf213884-bib-0032","first-page":"1166.e1","article-title":"Wild-type transthyretin cardiac amyloidosis: novel insights from advanced imaging","volume":"32","author":"Narotsky","year":"2016","journal-title":"Can J Cardiol"},{"key":"2026012114234249100_ehf213884-bib-0033","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1177\/2047487319877708","article-title":"Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings","volume":"27","author":"Vergaro","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"2026012114234249100_ehf213884-bib-0034","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1586\/14779072.2015.1069181","article-title":"Improving strategies for the diagnosis of cardiac amyloidosis","volume":"13","author":"Kourelis","year":"2015","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"2026012114234249100_ehf213884-bib-0035","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019840","article-title":"Recent advances and current dilemmas in the diagnosis and management of transthyretin cardiac amyloidosis","volume":"10","author":"Addison","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2026012114234249100_ehf213884-bib-0036","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/clc.23572","article-title":"Cardiac amyloidosis\u2014a review of current literature for the practicing physician","volume":"44","author":"Ash","year":"2021","journal-title":"Clin Cardiol"},{"key":"2026012114234249100_ehf213884-bib-0037","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s10741-020-10062-w","article-title":"Practical recommendations for the diagnosis and management of transthyretin cardiac amyloidosis","volume":"26","author":"Bistola","year":"2021","journal-title":"Heart Fail Rev"},{"key":"2026012114234249100_ehf213884-bib-0038","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.carrev.2020.06.005","article-title":"Cardiac amyloidosis in patients undergoing TAVR: why we need to think about it","volume":"22","author":"Cappelli","year":"2021","journal-title":"Cardiovasc Revasc Med"},{"key":"2026012114234249100_ehf213884-bib-0039","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.medcli.2020.06.064","article-title":"Transthyretin amyloid cardiomyopathy","volume":"156","author":"Garcia-Pavia","year":"2021","journal-title":"Med Clin (Barc)"},{"key":"2026012114234249100_ehf213884-bib-0040","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1002\/ehf2.13473","article-title":"Diagnosis of wild-type transthyretin amyloid cardiomyopathy in Japan: red-flag symptom clusters and diagnostic algorithm","volume":"8","author":"Inomata","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2026012114234249100_ehf213884-bib-0041","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s11899-021-00626-4","article-title":"Amyloidosis with cardiac involvement: identification, characterization, and management","volume":"16","author":"Jamal","year":"2021","journal-title":"Curr Hematol Malig Rep"},{"key":"2026012114234249100_ehf213884-bib-0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2021.100910","article-title":"Cardiac amyloidosis: presentations, diagnostic work-up and collaborative approach for comprehensive clinical management","volume":"46","author":"Joury","year":"2021","journal-title":"Curr Probl Cardiol"},{"key":"2026012114234249100_ehf213884-bib-0043","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.644508","article-title":"From clinical clues to final diagnosis: the return of detective work to clinical medicine in cardiac amyloidosis","volume":"8","author":"Sabbour","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"2026012114234249100_ehf213884-bib-0044","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11912-021-01028-8","article-title":"Updates in cardiac amyloidosis diagnosis and treatment","volume":"23","author":"Stern","year":"2021","journal-title":"Curr Oncol Rep"},{"key":"2026012114234249100_ehf213884-bib-0045","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1161\/CIR.0000000000000792","article-title":"Cardiac amyloidosis: evolving diagnosis and management: a scientific statement from the American Heart Association","volume":"142","author":"Kittleson","year":"2020","journal-title":"Circulation"},{"key":"2026012114234249100_ehf213884-bib-0046","first-page":"322","article-title":"Canadian Cardiovascular Society\/Canadian Heart Failure Society joint position statement on the evaluation and management of patients with cardiac amyloidosis","volume":"36","author":"Fine","year":"2020","journal-title":"Can J Cardiol"},{"key":"2026012114234249100_ehf213884-bib-0047","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1007\/s12350-019-01760-6","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2\u2014evidence base and standardized methods of imaging","volume":"26","author":"Dorbala","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"2026012114234249100_ehf213884-bib-0048","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s12350-019-01761-5","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI EXPERT consensus recommendations for multimodality imaging in cardiac amyloidosis: part 2 of 2\u2014diagnostic criteria and appropriate utilization","volume":"27","author":"Dorbala","year":"2020","journal-title":"J Nucl Cardiol"},{"key":"2026012114234249100_ehf213884-bib-0049","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006075","article-title":"Expert consensus recommendations for the suspicion and diagnosis of transthyretin cardiac amyloidosis","volume":"12","author":"Maurer","year":"2019","journal-title":"Circ Heart Fail"},{"key":"2026012114234249100_ehf213884-bib-0050","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/s00508-020-01781-z","article-title":"Diagnosis and treatment of cardiac amyloidosis: an interdisciplinary consensus statement","volume":"132","author":"Bonderman","year":"2020","journal-title":"Wien Klin Wochenschr"},{"key":"2026012114234249100_ehf213884-bib-0051","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases","volume":"42","author":"Garcia-Pavia","year":"2021","journal-title":"Eur Heart J"},{"key":"2026012114234249100_ehf213884-bib-0052","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/ehjci\/jeu107","article-title":"Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis","volume":"15","author":"Hutt","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026012114234249100_ehf213884-bib-0053","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"key":"2026012114234249100_ehf213884-bib-0054","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jcmg.2016.05.007","article-title":"Early phase 99Tc-HMDP scintigraphy for the diagnosis and typing of cardiac amyloidosis","volume":"10","author":"Galat","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026012114234249100_ehf213884-bib-0055","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.hlc.2016.12.017","article-title":"The utility of 99mTc-DPD scintigraphy in the diagnosis of cardiac amyloidosis: an Australian experience","volume":"26","author":"Moore","year":"2017","journal-title":"Heart Lung Circ"},{"key":"2026012114234249100_ehf213884-bib-0056","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ahj.2020.11.006","article-title":"A multi-modal diagnostic model improves detection of cardiac amyloidosis among patients with diagnostic confirmation by cardiac biopsy","volume":"232","author":"Zhang","year":"2021","journal-title":"Am Heart J"},{"key":"2026012114234249100_ehf213884-bib-0057","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1253\/circj.CJ-20-0110","article-title":"JCS 2020 guideline on diagnosis and treatment of cardiac amyloidosis","volume":"84","author":"Kitaoka","year":"2020","journal-title":"Circ J"},{"key":"2026012114234249100_ehf213884-bib-0058","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s10554-016-0915-z","article-title":"Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy","volume":"32","author":"Bennani Smires","year":"2016","journal-title":"Int J Cardiovasc Imaging"},{"key":"2026012114234249100_ehf213884-bib-0059","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jchf.2020.04.007","article-title":"Endomyocardial biopsy characterization of heart failure with preserved ejection fraction and prevalence of cardiac amyloidosis","volume":"8","author":"Hahn","year":"2020","journal-title":"JACC Heart Fail"},{"key":"2026012114234249100_ehf213884-bib-0060","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jacc.2016.06.033","article-title":"Natural history of wild-type transthyretin cardiac amyloidosis and risk stratification using a novel staging system","volume":"68","author":"Grogan","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026012114234249100_ehf213884-bib-0061","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jchf.2013.11.004","article-title":"Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction","volume":"2","author":"Mohammed","year":"2014","journal-title":"JACC Heart Fail"},{"key":"2026012114234249100_ehf213884-bib-0062","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.humpath.2011.03.004","article-title":"High prevalence of wild-type transthyretin deposition in patients with idiopathic carpal tunnel syndrome: a common cause of carpal tunnel syndrome in the elderly","volume":"42","author":"Sekijima","year":"2011","journal-title":"Hum Pathol"},{"key":"2026012114234249100_ehf213884-bib-0063","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.jacc.2018.07.092","article-title":"Tenosynovial and cardiac amyloidosis in patients undergoing carpal tunnel release","volume":"72","author":"Sperry","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026012114234249100_ehf213884-bib-0064","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s12265-019-09895-0","article-title":"Prevalence of cardiac amyloidosis in patients with carpal tunnel syndrome","volume":"12","author":"Zegri-Reiriz","year":"2019","journal-title":"J Cardiovasc Transl Res"},{"key":"2026012114234249100_ehf213884-bib-0065","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jacc.2016.03.596","article-title":"Genotype and phenotype of transthyretin cardiac amyloidosis: THAOS (transthyretin amyloid outcome survey)","volume":"68","author":"Maurer","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026012114234249100_ehf213884-bib-0066","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000098","article-title":"Senile systemic amyloidosis: clinical features at presentation and outcome","volume":"2","author":"Pinney","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"2026012114234249100_ehf213884-bib-0067","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1007\/s00392-019-01467-1","article-title":"Carpal tunnel syndrome and spinal canal stenosis: harbingers of transthyretin amyloid cardiomyopathy?","volume":"108","author":"aus dem Siepen","year":"2019","journal-title":"Clin Res Cardiol"},{"key":"2026012114234249100_ehf213884-bib-0068","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3109\/13506129.2015.1135792","article-title":"Carpal tunnel syndrome: a common initial symptom of systemic wild-type ATTR (ATTRwt) amyloidosis","volume":"23","author":"Nakagawa","year":"2016","journal-title":"Amyloid"},{"key":"2026012114234249100_ehf213884-bib-0069","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cardfail.2017.12.005","article-title":"Time course of common clinical manifestations in patients with transthyretin cardiac amyloidosis: delay from symptom onset to diagnosis","volume":"24","author":"Papoutsidakis","year":"2018","journal-title":"J Card Fail"},{"key":"2026012114234249100_ehf213884-bib-0070","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1161\/CIRCULATIONAHA.115.018852","article-title":"Heart failure resulting from age-related cardiac amyloid disease associated with wild-type transthyretin: a prospective, observational cohort study","volume":"133","author":"Connors","year":"2016","journal-title":"Circulation"},{"key":"2026012114234249100_ehf213884-bib-0071","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/0002-9343(83)90443-6","article-title":"Frequency and distribution of senile cardiovascular amyloid: a clinicopathologic correlation","volume":"75","author":"Cornwell","year":"1983","journal-title":"Am J Med"},{"key":"2026012114234249100_ehf213884-bib-0072","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/ejhf.1742","article-title":"Carpal tunnel syndrome in cardiac amyloidosis: implications for early diagnosis and prognostic role across the spectrum of aetiologies","volume":"22","author":"Milandri","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2026012114234249100_ehf213884-bib-0073","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/13506129.2017.1409706","article-title":"First nationwide survey on systemic wild-type ATTR amyloidosis in Japan","volume":"25","author":"Sekijima","year":"2018","journal-title":"Amyloid"},{"key":"2026012114234249100_ehf213884-bib-0074","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1002\/ehf2.12884","article-title":"Clinical characteristics and natural history of wild-type transthyretin amyloid cardiomyopathy in Japan","volume":"7","author":"Yamada","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2026012114234249100_ehf213884-bib-0075","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jacc.2019.04.054","article-title":"Association of carpal tunnel syndrome with amyloidosis, heart failure, and adverse cardiovascular outcomes","volume":"74","author":"Fosb\u00f8l","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026012114234249100_ehf213884-bib-0076","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/03009734.2014.895786","article-title":"Transthyretin-derived amyloidosis: probably a common cause of lumbar spinal stenosis","volume":"119","author":"Westermark","year":"2014","journal-title":"Ups J Med Sci"},{"key":"2026012114234249100_ehf213884-bib-0077","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/modpathol.2014.102","article-title":"Amyloid deposits derived from transthyretin in the ligamentum flavum as related to lumbar spinal canal stenosis","volume":"28","author":"Yanagisawa","year":"2015","journal-title":"Mod Pathol"},{"key":"2026012114234249100_ehf213884-bib-0078","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1185\/03007995.2012.754348","article-title":"THAOS\u2014the Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis","volume":"29","author":"Coelho","year":"2013","journal-title":"Curr Med Res Opin"},{"key":"2026012114234249100_ehf213884-bib-0079","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/13506129.2015.1028616","article-title":"Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role","volume":"22","author":"Longhi","year":"2015","journal-title":"Amyloid"},{"key":"2026012114234249100_ehf213884-bib-0080","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.jacc.2019.01.035","article-title":"High prevalence of intracardiac thrombi in cardiac amyloidosis","volume":"73","author":"Martinez-Naharro","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026012114234249100_ehf213884-bib-0081","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005066","article-title":"Occult transthyretin cardiac amyloid in severe calcific aortic stenosis: prevalence and prognosis in patients undergoing surgical aortic valve replacement","volume":"9","author":"Treibel","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026012114234249100_ehf213884-bib-0082","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jacc.2017.11.037","article-title":"Prevalence of cardiac amyloidosis in patients referred for transcatheter aortic valve replacement","volume":"71","author":"Scully","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026012114234249100_ehf213884-bib-0083","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/eurheartj\/ehx350","article-title":"Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement","volume":"38","author":"Casta\u00f1o","year":"2017","journal-title":"Eur Heart J"},{"key":"2026012114234249100_ehf213884-bib-0084","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jacc.2020.11.006","article-title":"Prevalence and outcomes of concomitant aortic stenosis and cardiac amyloidosis","volume":"77","author":"Nitsche","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2026012114234249100_ehf213884-bib-0085","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jcmg.2015.04.012","article-title":"Coexistence of degenerative aortic stenosis and wild-type transthyretin-related cardiac amyloidosis","volume":"9","author":"Longhi","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026012114234249100_ehf213884-bib-0086","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jacc.2003.08.043","article-title":"Noninvasive diagnosis of biopsy-proven cardiac amyloidosis","volume":"43","author":"Rahman","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2026012114234249100_ehf213884-bib-0087","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2015-000289","article-title":"Clinical, ECG and echocardiographic clues to the diagnosis of TTR-related cardiomyopathy","volume":"3","author":"Damy","year":"2016","journal-title":"Open Heart"},{"key":"2026012114234249100_ehf213884-bib-0088","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1161\/CIRCULATIONAHA.113.006242","article-title":"Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis","volume":"129","author":"Quarta","year":"2014","journal-title":"Circulation"},{"key":"2026012114234249100_ehf213884-bib-0089","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.amjcard.2014.07.026","article-title":"Prevalence and prognostic significance of low QRS voltage among the three main types of cardiac amyloidosis","volume":"114","author":"Cyrille","year":"2014","journal-title":"Am J Cardiol"},{"key":"2026012114234249100_ehf213884-bib-0090","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006619","article-title":"Baseline ECG features and arrhythmic profile in transthyretin versus light chain cardiac amyloidosis","volume":"13","author":"Cappelli","year":"2020","journal-title":"Circ Heart Fail"},{"key":"2026012114234249100_ehf213884-bib-0091","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ijcard.2016.04.030","article-title":"Are classic predictors of voltage valid in cardiac amyloidosis? A contemporary analysis of electrocardiographic findings","volume":"214","author":"Sperry","year":"2016","journal-title":"Int J Cardiol"},{"key":"2026012114234249100_ehf213884-bib-0092","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2217\/ahe.13.10","article-title":"Comparison of cardiac amyloidosis due to wild-type and V122I transthyretin in older adults referred to an academic medical center","volume":"9","author":"Givens","year":"2013","journal-title":"Aging Health"},{"key":"2026012114234249100_ehf213884-bib-0093","first-page":"1128","article-title":"Left atrial structure and function in cardiac amyloidosis","volume":"18","author":"Nochioka","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026012114234249100_ehf213884-bib-0094","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/clc.22353","article-title":"Echocardiographic and biohumoral characteristics in patients with AL and TTR amyloidosis at diagnosis","volume":"38","author":"Cappelli","year":"2015","journal-title":"Clin Cardiol"},{"key":"2026012114234249100_ehf213884-bib-0095","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.echo.2019.03.005","article-title":"Role of right ventricular strain measured by two-dimensional echocardiography in the diagnosis of cardiac amyloidosis","volume":"32","author":"Mo\u00f1ivas Palomero","year":"2019","journal-title":"J Am Soc Echocardiogr"},{"key":"2026012114234249100_ehf213884-bib-0096","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1136\/heartjnl-2012-302353","article-title":"Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis","volume":"98","author":"Phelan","year":"2012","journal-title":"Heart"},{"key":"2026012114234249100_ehf213884-bib-0097","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.echo.2014.04.015","article-title":"Application of a parametric display of two-dimensional speckle-tracking longitudinal strain to improve the etiologic diagnosis of mild to moderate left ventricular hypertrophy","volume":"27","author":"Phelan","year":"2014","journal-title":"J Am Soc Echocardiogr"},{"key":"2026012114234249100_ehf213884-bib-0098","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005588","article-title":"Echo parameters for differential diagnosis in cardiac amyloidosis: a head-to-head comparison of deformation and nondeformation parameters","volume":"10","author":"Pagourelias","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026012114234249100_ehf213884-bib-0099","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1253\/circj.CJ-14-1328","article-title":"Visual assessment of relative apical sparing pattern is more useful than quantitative assessment for diagnosing cardiac amyloidosis in borderline or mildly increased left ventricular wall thickness","volume":"79","author":"Lee","year":"2015","journal-title":"Circ J"},{"key":"2026012114234249100_ehf213884-bib-0100","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jcmg.2019.10.011","article-title":"Multiparametric echocardiography scores for the diagnosis of cardiac amyloidosis","volume":"13","author":"Boldrini","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026012114234249100_ehf213884-bib-0101","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jcmg.2019.03.026","article-title":"Noncontrast magnetic resonance for the diagnosis of cardiac amyloidosis","volume":"13","author":"Baggiano","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026012114234249100_ehf213884-bib-0102","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jcmg.2013.10.008","article-title":"Native T1 mapping in transthyretin amyloidosis","volume":"7","author":"Fontana","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026012114234249100_ehf213884-bib-0103","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jcmg.2018.02.006","article-title":"Native T1 and extracellular volume in transthyretin amyloidosis","volume":"12","author":"Martinez-Naharro","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026012114234249100_ehf213884-bib-0104","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jacc.2017.05.053","article-title":"Magnetic resonance in transthyretin cardiac amyloidosis","volume":"70","author":"Martinez-Naharro","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026012114234249100_ehf213884-bib-0105","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jcmg.2013.09.019","article-title":"CMR imaging with rapid visual T1 assessment predicts mortality in patients suspected of cardiac amyloidosis","volume":"7","author":"White","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026012114234249100_ehf213884-bib-0106","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jcmg.2013.08.015","article-title":"CMR-based differentiation of AL and ATTR cardiac amyloidosis","volume":"7","author":"Dungu","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026012114234249100_ehf213884-bib-0107","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1161\/CIRCULATIONAHA.115.016567","article-title":"Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis","volume":"132","author":"Fontana","year":"2015","journal-title":"Circulation"},{"key":"2026012114234249100_ehf213884-bib-0108","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1148\/radiol.2015141744","article-title":"Differential myocyte responses in patients with cardiac transthyretin amyloidosis and light-chain amyloidosis: a cardiac MR imaging study","volume":"277","author":"Fontana","year":"2015","journal-title":"Radiology"},{"key":"2026012114234249100_ehf213884-bib-0109","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3109\/13506129.2015.1020153","article-title":"Comparison of different types of cardiac amyloidosis by cardiac magnetic resonance imaging","volume":"22","author":"Kristen","year":"2015","journal-title":"Amyloid"},{"key":"2026012114234249100_ehf213884-bib-0110","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/ehf2.12203","article-title":"Diagnostic utility of cardiac troponin t level in patients with cardiac amyloidosis","volume":"5","author":"Takashio","year":"2018","journal-title":"ESC Heart Fail"},{"key":"2026012114234249100_ehf213884-bib-0111","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1161\/CIRCULATIONAHA.108.843334","article-title":"Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types","volume":"120","author":"Rapezzi","year":"2009","journal-title":"Circulation"},{"key":"2026012114234249100_ehf213884-bib-0112","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1093\/eurheartj\/ehv583","article-title":"Prevalence and clinical phenotype of hereditary transthyretin amyloid cardiomyopathy in patients with increased left ventricular wall thickness","volume":"37","author":"Damy","year":"2016","journal-title":"Eur Heart J"},{"key":"2026012114234249100_ehf213884-bib-0113","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173086","article-title":"Impact of genotype and phenotype on cardiac biomarkers in patients with transthyretin amyloidosis\u2014report from the Transthyretin Amyloidosis Outcome Survey (THAOS)","volume":"12","author":"Kristen","year":"2017","journal-title":"PLoS ONE"},{"key":"2026012114234249100_ehf213884-bib-0114","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/eurheartj\/ehx589","article-title":"A new staging system for cardiac transthyretin amyloidosis","volume":"39","author":"Gillmore","year":"2018","journal-title":"Eur Heart J"},{"key":"2026012114234249100_ehf213884-bib-0115","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/clinchem\/48.9.1437","article-title":"Serum reference intervals and diagnostic ranges for free \u03ba and free \u03bb immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains","volume":"48","author":"Katzmann","year":"2002","journal-title":"Clin Chem"},{"key":"2026012114234249100_ehf213884-bib-0116","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1515\/cclm-2015-0917","article-title":"Monitoring free light chains in serum using mass spectrometry","volume":"54","author":"Barnidge","year":"2016","journal-title":"Clin Chem Lab Med"},{"key":"2026012114234249100_ehf213884-bib-0117","first-page":"472","article-title":"A modern primer on light chain amyloidosis in 592 patients with mass spectrometry-verified typing","volume":"94","author":"Muchtar","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"2026012114234249100_ehf213884-bib-0118","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1080\/13506129.2018.1436048","article-title":"Monoclonal gammopathy of undetermined significance in systemic transthyretin amyloidosis (ATTR)","volume":"25","author":"Phull","year":"2018","journal-title":"Amyloid"},{"key":"2026012114234249100_ehf213884-bib-0119","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","article-title":"Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy","volume":"46","author":"Perugini","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2026012114234249100_ehf213884-bib-0120","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s00259-010-1642-7","article-title":"Usefulness and limitations of 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy","volume":"38","author":"Rapezzi","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026012114234249100_ehf213884-bib-0121","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.jcmg.2012.02.015","article-title":"Defining the diagnosis in echocardiographically suspected senile systemic amyloidosis","volume":"5","author":"Quarta","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026012114234249100_ehf213884-bib-0122","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/03009734.2015.1122687","article-title":"99mTc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis","volume":"121","author":"Pilebro","year":"2016","journal-title":"Ups J Med Sci"},{"key":"2026012114234249100_ehf213884-bib-0123","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCIMAGING.112.000132","article-title":"99mTc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses","volume":"6","author":"Bokhari","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026012114234249100_ehf213884-bib-0124","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/jamacardio.2016.2839","article-title":"Multicenter study of planar technetium 99m pyrophosphate cardiac imaging: predicting survival for patients with ATTR cardiac amyloidosis","volume":"1","author":"Castano","year":"2016","journal-title":"JAMA Cardiol"},{"key":"2026012114234249100_ehf213884-bib-0125","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/0002-8703(82)90331-3","article-title":"Value of positive myocardial technetium-99m-pyrophosphate scintigraphy in the noninvasive diagnosis of cardiac amyloidosis","volume":"103","author":"Wizenberg","year":"1982","journal-title":"Am Heart J"},{"key":"2026012114234249100_ehf213884-bib-0126","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/13506129.2013.871250","article-title":"Bone scintigraphy with 99mtechnetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis","volume":"21","author":"Glaudemans","year":"2014","journal-title":"Amyloid"},{"key":"2026012114234249100_ehf213884-bib-0127","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s12350-017-0922-z","article-title":"Accuracy of 99mTc-hydroxymethylene diphosphonate scintigraphy for diagnosis of transthyretin cardiac amyloidosis","volume":"26","author":"Cappelli","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"2026012114234249100_ehf213884-bib-0128","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.119.010249","article-title":"Efficient 1-hour technetium-99 m pyrophosphate imaging protocol for the diagnosis of transthyretin cardiac amyloidosis","volume":"13","author":"Masri","year":"2020","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026012114234249100_ehf213884-bib-0129","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1007\/s00259-018-4013-4","article-title":"Diagnostic accuracy of bone scintigraphy in the assessment of cardiac transthyretin-related amyloidosis: a bivariate meta-analysis","volume":"45","author":"Treglia","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026012114234249100_ehf213884-bib-0130","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jcmg.2016.06.003","article-title":"Can 99mTc-pyrophosphate aid in early detection of cardiac involvement in asymptomatic variant TTR amyloidosis?","volume":"10","author":"Haq","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026012114234249100_ehf213884-bib-0131","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jcmg.2014.03.004","article-title":"Identification of TTR-related subclinical amyloidosis with 99mTc-DPD scintigraphy","volume":"7","author":"Longhi","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026012114234249100_ehf213884-bib-0132","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/ajh.20745","article-title":"Suspected cardiac amyloidosis: endomyocardial biopsy remains the diagnostic gold-standard","volume":"82","author":"Kristen","year":"2007","journal-title":"Am J Hematol"},{"key":"2026012114234249100_ehf213884-bib-0133","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1001\/archinte.1988.00380030168027","article-title":"Endomyocardial biopsy in 30 patients with primary amyloidosis and suspected cardiac involvement","volume":"148","author":"Pellikka","year":"1988","journal-title":"Arch Intern Med"},{"key":"2026012114234249100_ehf213884-bib-0134","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s12872-016-0406-0","article-title":"Endomyocardial biopsy via the femoral access\u2014still safe and valuable diagnostic tool","volume":"16","author":"S\u0142awek","year":"2016","journal-title":"BMC Cardiovasc Disord"},{"key":"2026012114234249100_ehf213884-bib-0135","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1161\/CIRCULATIONAHA.109.924167","article-title":"Comparative evaluation of left and right ventricular endomyocardial biopsy: differences in complication rate and diagnostic performance","volume":"122","author":"Yilmaz","year":"2010","journal-title":"Circulation"},{"key":"2026012114234249100_ehf213884-bib-0136","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/dc.10370","article-title":"Fine-needle aspiration of abdominal fat pad for amyloid detection: a clinically useful test?","volume":"30","author":"Ansari-Lari","year":"2004","journal-title":"Diagn Cytopathol"},{"key":"2026012114234249100_ehf213884-bib-0137","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/13506129.2014.984063","article-title":"Sensitive and rapid assessment of amyloid by oligothiophene fluorescence in subcutaneous fat tissue","volume":"22","author":"Sj\u00f6lander","year":"2015","journal-title":"Amyloid"},{"key":"2026012114234249100_ehf213884-bib-0138","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1093\/eurheartj\/ehx047","article-title":"Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis","volume":"38","author":"Quarta","year":"2017","journal-title":"Eur Heart J"},{"key":"2026012114234249100_ehf213884-bib-0139","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.amjcard.2014.02.030","article-title":"Yield of noncardiac biopsy for the diagnosis of transthyretin cardiac amyloidosis","volume":"113","author":"Fine","year":"2014","journal-title":"Am J Cardiol"},{"key":"2026012114234249100_ehf213884-bib-0140","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1182\/blood-2014-11-609883","article-title":"A practical approach to the diagnosis of systemic amyloidoses","volume":"125","author":"Fern\u00e1ndez de Larrea","year":"2015","journal-title":"Blood"},{"key":"2026012114234249100_ehf213884-bib-0141","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/modpathol.2011.117","article-title":"Clinicopathological features of senile systemic amyloidosis: an ante-and post-mortem study","volume":"24","author":"Ueda","year":"2011","journal-title":"Mod Pathol"},{"key":"2026012114234249100_ehf213884-bib-0142","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1097\/PAS.0b013e3182263d74","article-title":"Strong transthyretin immunostaining: potential pitfall in cardiac amyloid typing","volume":"35","author":"Satoskar","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"2026012114234249100_ehf213884-bib-0143","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1136\/jclinpath-2014-202722","article-title":"A comparison of immunohistochemistry and mass spectrometry for determining the amyloid fibril protein from formalin-fixed biopsy tissue","volume":"68","author":"Gilbertson","year":"2015","journal-title":"J Clin Pathol"},{"key":"2026012114234249100_ehf213884-bib-0144","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/cjp2.126","article-title":"The complementary role of histology and proteomics for diagnosis and typing of systemic amyloidosis","volume":"5","author":"Rezk","year":"2019","journal-title":"J Pathol Clin Res"},{"key":"2026012114234249100_ehf213884-bib-0145","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1182\/blood-2009-07-230722","article-title":"Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens","volume":"114","author":"Vrana","year":"2009","journal-title":"Blood"},{"key":"2026012114234249100_ehf213884-bib-0146","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.jhsa.2019.06.016","article-title":"Carpal tunnel syndrome: a potential early, red-flag sign of amyloidosis","volume":"44","author":"Donnelly","year":"2019","journal-title":"J Hand Surg Am"},{"key":"2026012114234249100_ehf213884-bib-0147","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1142\/S2424835520500381","article-title":"The tenosynovitis of fingers associated with transthyretin amyloidosis","volume":"25","author":"Hara","year":"2020","journal-title":"J Hand Surg Asian Pac"},{"key":"2026012114234249100_ehf213884-bib-0148","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.2106\/JBJS.20.02093","article-title":"Diagnosing systemic amyloidosis presenting as carpal tunnel syndrome: a risk nomogram to guide biopsy at time of carpal tunnel release","volume":"103","author":"Sood","year":"2021","journal-title":"J Bone Joint Surg Am"},{"key":"2026012114234249100_ehf213884-bib-0149","article-title":"Hand surgeons and amyloidosis specialists warning: transthyretin-associated amyloidosis with bifid median nerve as a cause of bilateral carpal tunnel syndrome. A case report and literature review","author":"Triguero","year":"2021","journal-title":"Eur J Orthop Surg Traumatol"},{"key":"2026012114234249100_ehf213884-bib-0150","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1161\/CIRCULATIONAHA.118.038169","article-title":"Natural history, quality of life, and outcome in cardiac transthyretin amyloidosis","volume":"140","author":"Lane","year":"2019","journal-title":"Circulation"},{"key":"2026012114234249100_ehf213884-bib-0151","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.2215\/CJN.02290508","article-title":"Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease","volume":"3","author":"Hutchison","year":"2008","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ehf2.13884","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ehf2.13884","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/9\/3\/1524\/65668907\/eschf_9_3_1524.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/9\/3\/1524\/65668907\/eschf_9_3_1524.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:29:54Z","timestamp":1769023794000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/9\/3\/1524\/8362443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,27]]},"references-count":151,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3,27]]},"published-print":{"date-parts":[[2022,6,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.13884","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,6]]},"published":{"date-parts":[[2022,3,27]]},"assertion":[{"value":"2021-11-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}